Benjamin Robin Schrank MD PhD
Assistant Professor at UT MD Anderson Cancer Center (Radiation Oncology)
Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Schrank is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Benjamin Schrank is a radiation oncologist based in Houston, TX. He completed his MD and PhD at Columbia University Vagelos College of Physicians and Surgeons in 2020, followed by a transitional internship at Memorial Sloan Kettering Cancer Center (2020-2021), and then a residency in Radiation Oncology at the University of Texas MD Anderson Cancer Center (2021-2025). Prior to his medical training, he worked as a research technician at Massachusetts General Hospital from 2011 to 2013. Dr. Schrank has authored multiple publications in esteemed journals such as Nature, Nature Reviews Immunology, ACS Nano, and Nature Cancer, contributing to areas like mRNA vaccines, tumor antigens, and cancer immunotherapy.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2021 - 2025
Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2020 - 2021
Columbia University Vagelos College of Physicians and SurgeonsClass of 2020, MD, PhD
Certifications & Licensure
TX State Medical License 2025 - 2027
Publications & Presentations
PubMed
- Programming the immunological properties of mRNA vaccines for cancer.Annette Wu, Seong Dong Jeong, Benjamin R Schrank, Betty Y S Kim, Padmanee Sharma
Nature Reviews. Immunology. 2026-11-01 - Priming systemic immunity against glioblastoma.Annette Wu, Benjamin R Schrank
Nature Reviews. Immunology. 2026-10-29 - 3 citationsA transferable gut microbiota-bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response.Mengyu Chang, Yifan Wang, JongHoon Ha, Zoey R Neale, Nadim J Ajami
Nature Materials. 2026-09-01
Journal Articles
- Nuclear ARP2/3 Drives DNA Break Clustering for Homology-Directed RepairBenjamin Schrank, MD, Nature
Press Mentions
CPRIT Grants $22M to Bring Top Cancer Researchers to HoustonJune 17th, 2025- Novel Antibody-Toxin Conjugate (ATC) Prompts Immune System to Eliminate TumorsFebruary 26th, 2025
- MD Anderson Unveils New Antibody-Toxin ConjugateFebruary 26th, 2025
Grant Support
- Harnessing ecDNA Detection in Antigen-Presenting Cells for Anti-Tumor ImmunityUNIVERSITY OF TX MD ANDERSON CAN CTR2025–2030
Professional Memberships
- American Society for Radiation OncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: